RYANODEX DANTROLENE SODIUM FOR INJECTABLE SUSPENSION

Serial Number 86282422
Registration 4706981
710

Registration Progress

Application Filed
May 15, 2014
Under Examination
Approved for Publication
Jan 6, 2015
Published for Opposition
Jan 6, 2015
Registered
Mar 24, 2015

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: RYANODEX DANTROLENE SODIUM FOR INJECTABLE SUSPENSION
Previous Owner: Lyotropic Therapeutics, Inc.

Trademark Image

RYANODEX DANTROLENE SODIUM FOR INJECTABLE SUSPENSION

Basic Information

Serial Number
86282422
Registration Number
4706981
Filing Date
May 15, 2014
Registration Date
March 24, 2015
Published for Opposition
January 6, 2015
Cancellation Date
November 26, 2021
Drawing Code
3000

Status Summary

Current Status
Inactive
Status Code
710
Status Date
Nov 26, 2021

Rights Holder

Lyotropic Therapeutics, Inc.

03
Address
10487 Lakeridge Parkway
Ashland, VA 23005

Ownership History

Lyotropic Therapeutics, Inc.

Original Applicant
03
Ashland, VA

Lyotropic Therapeutics, Inc.

Owner at Publication
03
Ashland, VA

Lyotropic Therapeutics, Inc.

Original Registrant
03
Ashland, VA

Legal Representation

Attorney
Michelle Elizabeth Legiec

Application History

33 events
Date Code Type Description Documents
Nov 26, 2021 C8.. O CANCELLED SEC. 8 (6-YR) Loading...
Mar 24, 2020 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Mar 24, 2015 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jan 6, 2015 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 6, 2015 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 17, 2014 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 3, 2014 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Nov 29, 2014 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 30, 2014 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Oct 30, 2014 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Oct 14, 2014 ALIE A ASSIGNED TO LIE Loading...
Oct 11, 2014 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Sep 23, 2014 AAUA E NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED Loading...
Sep 22, 2014 CEPE I COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED Loading...
Sep 22, 2014 ALIE A ASSIGNED TO LIE Loading...
Sep 21, 2014 GEAN O NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED Loading...
Sep 21, 2014 GEAP O EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED Loading...
Sep 21, 2014 CPEA R EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED Loading...
Sep 21, 2014 IUAA P USE AMENDMENT ACCEPTED Loading...
Sep 6, 2014 AUPC I AMENDMENT TO USE PROCESSING COMPLETE Loading...
Sep 6, 2014 IUAF S USE AMENDMENT FILED Loading...
Sep 5, 2014 EAAU I TEAS AMENDMENT OF USE RECEIVED Loading...
Sep 5, 2014 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Sep 5, 2014 GNRT F NON-FINAL ACTION E-MAILED Loading...
Sep 5, 2014 CNRT R NON-FINAL ACTION WRITTEN Loading...
Aug 29, 2014 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 25, 2014 TAEA I TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED Loading...
Jul 25, 2014 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED Loading...
May 30, 2014 TAEA I TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED Loading...
May 30, 2014 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED Loading...
May 30, 2014 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
May 29, 2014 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 19, 2014 NWAP I NEW APPLICATION ENTERED Loading...

Additional Information

Design Mark
The mark consists of the word "RYANODEX in blue above the words "DANTROLENE SODIUM" in black enclosed within black parenthesis which is directly above the words "FOR INJECTABLE SUSPENSION" in black. Directly below the "A" in "RYANODEX" is a stylized arrow consisting of the color orange at the nock of the arrow, transitioning to red along the shaft and then becoming blue where the shaft bends and remaining blue toward the head of the arrow.
Color Claim
The color(s) black, orange, red and blue is/are claimed as a feature of the mark.

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"(DANTROLENE SODIUM)" AND "FOR INJECTABLE SUSPENSION"